PL377494A1 - Krystaliczny, niesolwatowany chlorowodorek 1-(4-(2-pipe-rydynyloetoksy) fenoksy)-2-(4-metanosulfonylofenylo)-6- hydroksynaftalenu - Google Patents
Krystaliczny, niesolwatowany chlorowodorek 1-(4-(2-pipe-rydynyloetoksy) fenoksy)-2-(4-metanosulfonylofenylo)-6- hydroksynaftalenuInfo
- Publication number
- PL377494A1 PL377494A1 PL377494A PL37749404A PL377494A1 PL 377494 A1 PL377494 A1 PL 377494A1 PL 377494 A PL377494 A PL 377494A PL 37749404 A PL37749404 A PL 37749404A PL 377494 A1 PL377494 A1 PL 377494A1
- Authority
- PL
- Poland
- Prior art keywords
- piperidinylethoxy
- methanesulfonylphenyl
- solvated
- phenoxy
- crystalline non
- Prior art date
Links
- BUCLTGYHCZKFSR-UHFFFAOYSA-N 6-(4-methylsulfonylphenyl)-5-[4-(2-piperidin-1-ylethoxy)phenoxy]naphthalen-2-ol;hydrochloride Chemical compound Cl.C1=CC(S(=O)(=O)C)=CC=C1C1=CC=C(C=C(O)C=C2)C2=C1OC(C=C1)=CC=C1OCCN1CCCCC1 BUCLTGYHCZKFSR-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45023303P | 2003-02-25 | 2003-02-25 | |
| PCT/IB2003/003349 WO2004009086A1 (en) | 2002-07-22 | 2003-07-16 | Selective estrogen receptor modulators containing a phenylsulfonyl group |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL377494A1 true PL377494A1 (pl) | 2006-02-06 |
Family
ID=36680233
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL377494A PL377494A1 (pl) | 2003-02-25 | 2004-01-21 | Krystaliczny, niesolwatowany chlorowodorek 1-(4-(2-pipe-rydynyloetoksy) fenoksy)-2-(4-metanosulfonylofenylo)-6- hydroksynaftalenu |
Country Status (9)
| Country | Link |
|---|---|
| JP (1) | JP2007537991A (pl) |
| KR (1) | KR100693242B1 (pl) |
| CN (1) | CN100348192C (pl) |
| CO (1) | CO5590928A2 (pl) |
| EA (1) | EA007978B1 (pl) |
| EC (1) | ECSP055976A (pl) |
| NZ (1) | NZ541126A (pl) |
| PL (1) | PL377494A1 (pl) |
| ZA (1) | ZA200506547B (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116438177B (zh) * | 2021-01-28 | 2025-09-16 | 江苏亚虹医药科技股份有限公司 | 靶向嵌合化合物、含其的药物组合物及其制备方法和用途 |
| WO2022237904A1 (zh) * | 2021-05-14 | 2022-11-17 | 江苏亚虹医药科技股份有限公司 | 一种含萘环的化合物、含其的药物组合物及其应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7501441B1 (en) * | 1994-09-20 | 2009-03-10 | Eli Lilly And Company | Naphthyl compounds, intermediates, processes, compositions, and methods |
| US5998401A (en) * | 1995-02-28 | 1999-12-07 | Eli Lilly And Company | Naphthyl compounds, intermediates, compositions, and methods |
| PT791591E (pt) * | 1996-02-22 | 2001-12-28 | Lilly Co Eli | Benzotiofenos, formulacoes que os contem e metodos |
| CA2217810A1 (en) * | 1996-10-10 | 1998-04-10 | Eli Lilly And Company | 2-aryl-3-aminoaryloxynaphthyl compounds, intermediates, compositions and methods |
| ATE433322T1 (de) * | 2002-07-22 | 2009-06-15 | Lilly Co Eli | Selektive östrogenrezeptor modulatoren, die eine phenylsulfonyl-gruppe enthalten |
-
2004
- 2004-01-21 CN CNB200480005160XA patent/CN100348192C/zh not_active Expired - Fee Related
- 2004-01-21 EA EA200501339A patent/EA007978B1/ru not_active IP Right Cessation
- 2004-01-21 PL PL377494A patent/PL377494A1/pl not_active Application Discontinuation
- 2004-01-21 NZ NZ541126A patent/NZ541126A/en unknown
- 2004-01-21 KR KR1020057015644A patent/KR100693242B1/ko not_active Expired - Fee Related
- 2004-01-21 JP JP2006536491A patent/JP2007537991A/ja active Pending
-
2005
- 2005-08-16 ZA ZA200506547A patent/ZA200506547B/en unknown
- 2005-08-23 EC EC2005005976A patent/ECSP055976A/es unknown
- 2005-08-24 CO CO05084345A patent/CO5590928A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2007537991A (ja) | 2007-12-27 |
| ECSP055976A (es) | 2006-01-16 |
| KR100693242B1 (ko) | 2007-03-12 |
| NZ541126A (en) | 2008-07-31 |
| EA007978B1 (ru) | 2007-02-27 |
| EA200501339A1 (ru) | 2006-02-24 |
| CN1753676A (zh) | 2006-03-29 |
| KR20050106039A (ko) | 2005-11-08 |
| CO5590928A2 (es) | 2005-12-30 |
| CN100348192C (zh) | 2007-11-14 |
| ZA200506547B (en) | 2006-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200803926B (en) | 2-(Phenyl or heterocyclic)-1H-phenantrho[9,10-D]imidazoles as MPGES-1 inhibitors | |
| AU2003211424A1 (en) | Nitrogen-containing heterocyclic compound | |
| AU2003278088A1 (en) | Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors | |
| AU2003245555A1 (en) | Sphingosine kinase inhibitors | |
| GB0306911D0 (en) | Packet buffer management | |
| AU2003302238A8 (en) | 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors | |
| PL374893A1 (pl) | Pochodne 1-(4-benzylo-piperazyn-1-ylo)-3-fenylo-propenonu | |
| SI1505066T1 (sl) | Polimorf 4-(2-(4-(1-(2-etoksietil)-1h-benzimidazol-2-il) -1-piperidinil)-alfa, alfa-dimetil-benzenocetne kisline | |
| AU2003264386A1 (en) | 4-(substituted aryl)-5-hydroxyisoquinolinone derivative | |
| GB0320866D0 (en) | Data management tool | |
| CR7962A (es) | Clorhidrato de 1-(4-(2-piperidiniletoxi) Fenoxi)-2-(-4Metanosulfonifenil)-6-Hidroxinaftaleno Cristalino no solvatado | |
| PL377494A1 (pl) | Krystaliczny, niesolwatowany chlorowodorek 1-(4-(2-pipe-rydynyloetoksy) fenoksy)-2-(4-metanosulfonylofenylo)-6- hydroksynaftalenu | |
| AU2003296393A1 (en) | Factor xa inhibitors | |
| HK1085925A (en) | Crystalline non-solvated 1-(4-(2-piperidinylethoxy)phenoxy)-2-(4-methanesulfonylphenyl)-6-hydroxynaphthalene hydrochloride | |
| EP1623798A4 (en) | MECHANICAL NAILER | |
| WO2005036424A8 (de) | Werkzeug für die unternehmensführung | |
| AU2003257407A1 (en) | S-(+)-3-{1-(2-(2,3-dihydro-1h-indol-3-yl)ethyl)-3,6-dihydro-2h-pyridin-4-yl}-6-chloro-1h-indole and acid addition salts thereof | |
| MXPA05009098A (es) | Clorhidrato de 1- (4-(2 -piperidiniletoxifenoxi) -2-(4-metansulfonilfenil) -6-hidroxinaftaleno cristalino no solvatado. | |
| AU2003278418A1 (en) | Amorphous moxifloxacin hydrochloride | |
| AU2003252653A1 (en) | Nailing machine | |
| AU2002353583A1 (en) | Nailing machine | |
| AU2003238590A1 (en) | Tablets comprising ciprofloxacin hydrochloride | |
| TWI347183B (en) | 2-(1h-indolylsulfanyl)-benzyl amine derivatives | |
| AU2002368314A1 (en) | Iminosugar derivatives as glucosidase inhibitors | |
| AU2003237945A1 (en) | Crystalline (r)-2-(4-amidinophenylaminomethyl)-1-methyl-5-(1-(carboxymethylamino)-1(pyrrolidinocarbonyl)-ethyl)-benzimidazole, and the use thereof as antithrombotic agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |